Cargando…
Assessment of Viral Genotype Impact to the Cost-Effectiveness and Overall Costs of Care for Peg-Interferon-2α + Ribavirine Treated Chronic Hepatitis C Patients
BACKGROUND: Pegylated interferon alfa plus ribavirin protocol is currently considered the most efficient hepatitis C treatment. However, no evidence of costs comparison among common viral genotypes has been published. OBJECTIVES: We aimed to assess core drivers of hepatitis C medical care costs and...
Autores principales: | Jakovljevic, Mihajlo, Mijailovic, Zeljko, Popovska Jovicic, Biljana, Canovic, Predrag, Gajovic, Olgica, Jovanovic, Mirjana, Petrovic, Dejan, Milovanovic, Olivera, Djordjevic, Natasa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kowsar
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3768202/ https://www.ncbi.nlm.nih.gov/pubmed/24032044 http://dx.doi.org/10.5812/hepatmon.6750 |
Ejemplares similares
-
Potential Hepatoprotective Role of Galectin-3 during HCV Infection in End-Stage Renal Disease Patients
por: Lukic, Ruzica, et al.
Publicado: (2017) -
Galectin-1 as the new player in staging and prognosis of COVID-19
por: Markovic, Sofija Sekulic, et al.
Publicado: (2022) -
LAT Software Induced Savings on Medical Costs of Alcohol Addicts' Care - Results from a Matched-Pairs Case-Control Study
por: Jakovljevic, Mihajlo, et al.
Publicado: (2014) -
SARS-CoV-2 infection induces mixed M1/M2 phenotype in circulating monocytes and alterations in both dendritic cell and monocyte subsets
por: Matic, Sanja, et al.
Publicado: (2020) -
Vitamin D, Albumin, and D-Dimer as Significant Prognostic Markers in Early Hospitalization in Patients with COVID-19
por: Popovska Jovičić, Biljana, et al.
Publicado: (2023)